Group One Trading, L.P. Blueprint Medicines Corp Transaction History

Group One Trading, L.P.

$2.2 Billion
Q1 2025

A detailed history of Group One Trading, L.P. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Group One Trading, L.P. holds 11,452 shares of BPMC stock, worth $1.46 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

11,452

Previous 47,194 75.73%

Holding current value

$1.46 Million

Previous $4.12 Million 75.39%

% of portfolio

0.05%

Previous 0.15%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 14, 2025	SELL	$86.69 - $115.63 $3.1 Million - $4.13 Million	-35,742 Reduced 75.73%	11,452 $1.01 Million
Q4 2024 Feb 14, 2025	SELL	$82.48 - $101.39 $269,462 - $331,241	-3,267 Reduced 6.47%	47,194 $4.12 Million
Q3 2024 Nov 14, 2024	BUY	$84.1 - $120.5 $4.24 Million - $6.08 Million	50,461 New	50,461 $4.67 Million
Q3 2023 Nov 09, 2023	BUY	$46.9 - $66.0 $1.29 Million - $1.82 Million	27,583 Added 104.98%	53,858 $2.7 Million
Q2 2023 Aug 09, 2023	BUY	$42.2 - $66.37 $619,116 - $973,714	14,671 Added 126.43%	26,275 $1.66 Million
Q1 2023 May 12, 2023	BUY	$37.97 - $50.0 $198,507 - $261,400	5,228 Added 81.99%	11,604 $522,000
Q4 2022 Feb 09, 2023	BUY	$41.06 - $66.48 $69,966 - $113,281	1,704 Added 36.47%	6,376 $279,000
Q3 2022 Nov 09, 2022	BUY	$49.93 - $77.7 $220,490 - $343,123	4,416 Added 1725.0%	4,672 $308,000
Q2 2022 Aug 11, 2022	BUY	$45.23 - $70.15 $11,578 - $17,958	256 New	256 $13,000
Q1 2022 May 12, 2022	SELL	$54.1 - $110.08 $81,150 - $165,120	-1,500 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$94.25 - $115.99 $377,000 - $463,960	-4,000 Reduced 72.73%	1,500 $161,000
Q3 2021 Nov 12, 2021	BUY	$80.98 - $109.47 $410,325 - $554,684	5,067 Added 1170.21%	5,500 $565,000
Q2 2021 Aug 10, 2021	BUY	$82.78 - $101.0 $8,278 - $10,100	100 Added 30.03%	433 $38,000
Q1 2021 May 12, 2021	BUY	$90.71 - $108.28 $30,206 - $36,057	333 New	333 $32,000
Q1 2020 May 13, 2020	SELL	$48.11 - $82.22 $392,914 - $671,490	-8,167 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$66.73 - $82.59 $355,270 - $439,709	5,324 Added 187.27%	8,167 $654,000
Q3 2019 Nov 12, 2019	BUY	$72.9 - $101.41 $207,254 - $288,308	2,843 New	2,843 $209,000
Q1 2019 May 13, 2019	SELL	$48.7 - $86.6 $348,594 - $619,882	-7,158 Closed	0 $0
Q4 2018 Feb 06, 2019	BUY	$45.57 - $74.26 $176,948 - $288,351	3,883 Added 118.56%	7,158 $386,000
Q3 2018 Nov 08, 2018	SELL	$58.91 - $78.32 $149,277 - $198,462	-2,534 Reduced 43.62%	3,275 $256,000
Q2 2018 Aug 14, 2018	BUY	$60.96 - $101.18 $354,116 - $587,754	5,809 New	5,809 $369,000

Others Institutions Holding BPMC

# of Institutions

391

Shares Held

68.5M

Call Options Held

1.54M

Put Options Held

1.08M

View Full List

About Blueprint Medicines Corp

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $7.62B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

More about BPMC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Group One Trading, L.P. with notifications on news.

Account

Group One Trading, L.P. Blueprint Medicines Corp Transaction History